Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Pemetrexed in Advanced NSCLC (JMEN)
NCT00102804Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Mar 2005; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00102804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102804.